erythromycin
Generic: erythromycin
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
erythromycin
Generic Name
erythromycin
Labeler
asclemed usa, inc.
Dosage Form
OINTMENT
Routes
Active Ingredients
erythromycin 5 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
76420-212
Product ID
76420-212_d9ae93e7-f4a8-1df3-e053-2a95a90ae5b1
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA064030
Listing Expiration
2026-12-31
Marketing Start
1996-07-18
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420212
Hyphenated Format
76420-212
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
erythromycin (source: ndc)
Generic Name
erythromycin (source: ndc)
Application Number
ANDA064030 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/g
Packaging
- 1 TUBE in 1 CARTON (76420-212-30) / 3.5 g in 1 TUBE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "d9ae93e7-f4a8-1df3-e053-2a95a90ae5b1", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "unii": ["63937KV33D"], "rxcui": ["310149"], "spl_set_id": ["bccdb8f3-b5f5-4f07-8ddb-8811d5c1b73c"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (76420-212-30) / 3.5 g in 1 TUBE", "package_ndc": "76420-212-30", "marketing_start_date": "20220308"}], "brand_name": "Erythromycin", "product_id": "76420-212_d9ae93e7-f4a8-1df3-e053-2a95a90ae5b1", "dosage_form": "OINTMENT", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "76420-212", "generic_name": "Erythromycin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "5 mg/g"}], "application_number": "ANDA064030", "marketing_category": "ANDA", "marketing_start_date": "19960718", "listing_expiration_date": "20261231"}